MXPA02007298A - Composiciones farmaceuticas electrostaticamente hiladas. - Google Patents

Composiciones farmaceuticas electrostaticamente hiladas.

Info

Publication number
MXPA02007298A
MXPA02007298A MXPA02007298A MXPA02007298A MXPA02007298A MX PA02007298 A MXPA02007298 A MX PA02007298A MX PA02007298 A MXPA02007298 A MX PA02007298A MX PA02007298 A MXPA02007298 A MX PA02007298A MX PA02007298 A MXPA02007298 A MX PA02007298A
Authority
MX
Mexico
Prior art keywords
agent
further characterized
poly
water
composition according
Prior art date
Application number
MXPA02007298A
Other languages
English (en)
Spanish (es)
Inventor
Francis Ignatious
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MXPA02007298A publication Critical patent/MXPA02007298A/es

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Textile Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
MXPA02007298A 2000-01-28 2001-01-25 Composiciones farmaceuticas electrostaticamente hiladas. MXPA02007298A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17868200P 2000-01-28 2000-01-28
PCT/US2001/002399 WO2001054667A1 (en) 2000-01-28 2001-01-25 Electrospun pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MXPA02007298A true MXPA02007298A (es) 2002-12-09

Family

ID=22653497

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02007298A MXPA02007298A (es) 2000-01-28 2001-01-25 Composiciones farmaceuticas electrostaticamente hiladas.

Country Status (18)

Country Link
EP (1) EP1251829A4 (ja)
JP (1) JP2003521493A (ja)
KR (1) KR100806412B1 (ja)
CN (1) CN1223340C (ja)
AR (1) AR028204A1 (ja)
AU (1) AU772830B2 (ja)
BR (1) BR0107869A (ja)
CA (1) CA2396640A1 (ja)
HU (1) HUP0301130A3 (ja)
IL (1) IL150642A0 (ja)
MX (1) MXPA02007298A (ja)
MY (1) MY129356A (ja)
NO (1) NO20023338L (ja)
NZ (1) NZ519992A (ja)
PL (1) PL356924A1 (ja)
TW (1) TWI289061B (ja)
WO (1) WO2001054667A1 (ja)
ZA (1) ZA200205989B (ja)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
EP1333808B1 (en) * 2000-10-18 2012-07-25 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed composition used in drug delivery and cell encapsulation
ES2312495T3 (es) * 2000-11-17 2009-03-01 Virginia Commonwealth University Intellectual Property Foundation Colageno electroprocesado.
JP2010163435A (ja) * 2000-11-17 2010-07-29 Virginia Commonwealth Univ Intellectual Property Foundation 電気処理されたコラーゲン
WO2002074190A2 (en) * 2001-03-20 2002-09-26 Nicast Ltd. Polymer fiber tubular structure having improved kinking resistance
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
KR100549140B1 (ko) 2002-03-26 2006-02-03 이 아이 듀폰 디 네모아 앤드 캄파니 일렉트로-브로운 방사법에 의한 초극세 나노섬유 웹제조방법
BRPI0309022A2 (pt) 2002-04-04 2016-11-08 Univ Akron conjuntos de fibra não tecida
US8367570B2 (en) 2002-04-04 2013-02-05 The University Of Akron Mechanically strong absorbent non-woven fibrous mats
AU2003221677A1 (en) * 2002-04-11 2003-10-27 Secant Medical, Inc. Covering process using electrospinning of very small fibers
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
WO2004062697A2 (en) 2003-01-07 2004-07-29 Tufts University Silk fibroin materials and use thereof
JP2007501218A (ja) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
EP1701704A2 (en) 2003-12-31 2006-09-20 Pfizer Products Inc. Solid compositions of low-solubility drugs and poloxamers
JP4526851B2 (ja) * 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
WO2006006746A1 (en) * 2004-07-09 2006-01-19 Hak-Yong Kim Polymer particles, and a method for manufacturing the same
CN100577720C (zh) * 2005-03-21 2010-01-06 中国科学院化学研究所 可生物降解及吸收的聚合物纳米纤维膜材料及制法和用途
JP2006299459A (ja) * 2005-04-20 2006-11-02 National Institute For Materials Science 生分解性高分子不織布チューブの製造方法
CN1300393C (zh) * 2005-07-01 2007-02-14 中国科学院长春应用化学研究所 超细纤维药物剂型的乳液电纺丝制备方法
DE112006001898B4 (de) * 2005-07-21 2013-05-08 National Institute For Materials Science Vorrichtung zur Inhalation von Arzneimitteln
JP4787585B2 (ja) * 2005-09-29 2011-10-05 帝人株式会社 静電紡糸法による繊維構造体の製造方法
CN100556399C (zh) * 2005-12-23 2009-11-04 中国科学院广州化学研究所 一种肠靶向型药物控释纤维及其制备方法
US8367112B2 (en) 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
KR100824719B1 (ko) * 2006-09-04 2008-04-24 주식회사 아모메디 전분함유 나노섬유 부직포로 이루어진 생분해성 식품포장재 및 그 제조방법
EP2271301A4 (en) 2008-03-27 2014-07-02 Agigma Inc METHODS AND COMPOSITIONS FOR THE DELIVERY OF AGENTS
EP2666457B1 (en) 2008-04-16 2020-06-17 The Procter & Gamble Company Process for forming a non-lathering personal care article in the form of a dissolvable solid foam
CN102176905A (zh) * 2008-08-08 2011-09-07 巴斯夫欧洲公司 具有受控释放的活性成分的含活性成分的纤维层状结构，其用途及其生产方法
EP2328567A2 (de) 2008-08-08 2011-06-08 Basf Se Wirkstoffhaltige fasernflächengebilde auf basis von biopolymeren, ihre anwendungen und verfahren zu ihrer herstellung
CN101721751B (zh) * 2008-10-10 2013-01-02 张阳德 负载了缓释细胞生长因子的具有内核的中空二氧化硅球的人体组织工程支架及其制法和用途
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
KR101065255B1 (ko) * 2009-02-13 2011-09-16 김근형 생분해성 폴리머의 전기방사를 이용한 신규 약물 전달 시스템
CN101559242B (zh) * 2009-05-22 2015-07-29 广州迈普再生医学科技有限公司 一种可同时作为药物缓释体系的纳米人工硬脑膜及其制备方法
WO2011029777A1 (de) 2009-09-11 2011-03-17 Basf Se Verfahren zur herstellung von beschichteten polymerfasern
CN102647972B (zh) 2009-12-08 2013-12-11 宝洁公司 可溶性多孔固体基质和包含基质微球体的表面驻留涂层
US9173826B2 (en) 2010-02-16 2015-11-03 The Procter & Gamble Company Porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione
CN101816627B (zh) * 2010-04-16 2012-03-07 浙江大学 一种协同治疗型多物质缓释滴眼剂及制备方法
RU2541275C2 (ru) * 2010-07-02 2015-02-10 Дзе Проктер Энд Гэмбл Компани Филаменты, содержащие неароматизированный активный агент, нетканые полотна и способы их получения
BR112012033600A2 (pt) * 2010-07-02 2016-11-29 Procter & Gamble Comapny filamentos compreendendo mantas de não-tecido com agente ingerível e métodos de fabricação dos mesmos.
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
CA2803629C (en) 2010-07-02 2015-04-28 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
WO2012003350A1 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
MX2012015072A (es) 2010-07-02 2013-02-07 Procter & Gamble Articulo con estructura soluble de trama fibrosa que comprende agentes activos.
EP2588655B1 (en) 2010-07-02 2017-11-15 The Procter and Gamble Company Method for delivering an active agent
HUE030120T2 (en) 2010-07-02 2017-04-28 Procter & Gamble Procedure for forming a film from a non-woven web
RU2553294C2 (ru) 2010-07-02 2015-06-10 Дзе Проктер Энд Гэмбл Компани Материал в виде полотна и способ его изготовления
CN101915797B (zh) * 2010-07-27 2011-09-28 北京师范大学 一种静电纺丝固定化漆酶电极的制备方法
US9808418B2 (en) 2010-11-26 2017-11-07 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form
WO2012084427A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions comprising structured non-aqueous liquid phase
WO2012084441A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions in the form of fibres
CZ201124A3 (cs) 2011-01-17 2012-06-13 Elmarco S.R.O. Nosic pro oromukosální, zejména pro sublingvální aplikaci fyziologicky aktivních látek
CN102251317B (zh) * 2011-05-18 2013-01-16 东华大学 一种药物释放可控的电纺纤维的制备方法
WO2013124869A2 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
CN102631715A (zh) * 2012-05-04 2012-08-15 江南大学 一种抗凝血纳米纤维膜的制备方法
CN102670483B (zh) * 2012-05-09 2014-04-02 上海交通大学 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法
CN102697727B (zh) * 2012-06-12 2014-01-08 东华大学 一种利用静电纺丝技术制备自组装酮洛芬脂质体的方法
KR101454360B1 (ko) 2012-08-31 2014-10-24 서울대학교산학협력단 파에도닥틸룸 트리코르누툼 추출물을 함유하는 젤라틴 나노섬유 지지체 및 이를 이용한 창상피복재
CN104884037B (zh) 2012-10-12 2018-02-16 宝洁公司 可溶性制品形式的个人护理组合物
WO2014131376A1 (en) * 2013-02-26 2014-09-04 Elmarco S.R.O. Electrospun nanofibers comprising pharmaceutically active agents
CN105246469A (zh) 2013-03-12 2016-01-13 活性纤维有限公司 纳米纤维和生物活性组合物及相关方法
EP2813212A1 (en) 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
US10202636B2 (en) 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
WO2015164227A2 (en) 2014-04-22 2015-10-29 The Procter & Gamble Company Compositions in the form of dissolvable solid structures
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
WO2015189212A1 (en) * 2014-06-10 2015-12-17 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
CN105362269A (zh) * 2014-09-01 2016-03-02 天津药物研究院 一种含蔗糖的罗氟司特片及其制备方法
JPWO2016159240A1 (ja) * 2015-03-31 2018-02-01 Ｏｒｔｈｏｒｅｂｉｒｔｈ株式会社 エレクトロスピニングを用いた、薬剤を含有する生分解性繊維素材の製造方法
CN108025477A (zh) * 2015-07-07 2018-05-11 新加坡保健服务集团 聚合物产品及其制备
CN105327357B (zh) * 2015-10-14 2019-01-11 北京科技大学 一种邻苯二酚修饰的透明质酸的载药系统及其制备方法
SG10201913222XA (en) * 2015-11-19 2020-03-30 Afyx Therapeutics As A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
JP7126260B2 (ja) * 2016-01-27 2022-08-26 インスター テクノロジーズ アクチオヴァ スプルチュノスト 治療処置用の口腔粘膜ナノファイバ担体
CN105727358B (zh) * 2016-02-23 2019-01-22 广西易得佳医疗器械有限公司 载药生物高分子复合纳米纤维膜及其制备方法
CN105663025A (zh) * 2016-02-29 2016-06-15 浙江工业大学 一种含药微丝及其制备方法
DK3570821T3 (da) 2017-01-23 2021-10-11 Afyx Therapeutics As Fremgangsmåde til fremstilling af et tolagsprodukt på basis af elektrospundne fibre
CA3050026A1 (en) 2017-01-23 2018-07-26 Afyx Therapeutics A/S Method for preparing electrospun fibers with a high content of a bioadhesive substance
MX2019008761A (es) 2017-01-27 2019-09-18 Procter & Gamble Composiciones en la forma de estructuras solidas solubles que comprenden particulas aglomeradas efervescentes.
EP3573593B1 (en) 2017-01-27 2023-08-30 The Procter & Gamble Company Compositions in the form of dissolvable solid structures
JP6923673B2 (ja) 2017-05-16 2021-08-25 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 溶解性固形構造体の形態のコンディショニングヘアケア組成物
CN107447366A (zh) * 2017-08-03 2017-12-08 东华大学 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用
JP7127135B2 (ja) 2018-01-26 2022-08-29 ザ プロクター アンド ギャンブル カンパニー 水溶性物品及び関連プロセス
CN111542590A (zh) 2018-01-26 2020-08-14 宝洁公司 包含香料的水溶性单位剂量制品
CN111556891B (zh) 2018-01-26 2021-11-05 宝洁公司 包含酶的水溶性单位剂量制品
WO2019147532A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
JP7121944B2 (ja) * 2018-05-07 2022-08-19 国立大学法人信州大学 ナノ繊維及びその製造方法
JP1629688S (ja) 2018-07-16 2019-04-15
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
EP3918045A1 (en) 2019-01-28 2021-12-08 The Procter & Gamble Company Recycleable, renewable, or biodegradable package
EP3712237A1 (en) 2019-03-19 2020-09-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
BR112021023244A2 (pt) 2019-06-28 2022-01-04 Procter & Gamble Artigos fibrosos sólidos dissolvíveis contendo tensoativos aniônicos
JP7393441B2 (ja) 2019-07-03 2023-12-06 ザ プロクター アンド ギャンブル カンパニー カチオン性界面活性剤及び可溶性酸を含有する繊維構造体
USD939359S1 (en) 2019-10-01 2021-12-28 The Procter And Gamble Plaza Packaging for a single dose personal care product
WO2021077133A1 (en) 2019-10-14 2021-04-22 The Procter & Gamble Company Biodegradable and/or home compostable sachet containing a solid article
JP7359958B2 (ja) 2019-11-20 2023-10-11 ザ プロクター アンド ギャンブル カンパニー 多孔質溶解性固体構造体
MX2022005532A (es) 2019-12-01 2022-06-08 Procter & Gamble Composiciones acondicionadoras para el cabello con un sistema de conservacion que contiene benzoato de sodio y glicoles y/o esteres de glicerilo.
USD941051S1 (en) 2020-03-20 2022-01-18 The Procter And Gamble Company Shower hanger
USD962050S1 (en) 2020-03-20 2022-08-30 The Procter And Gamble Company Primary package for a solid, single dose beauty care composition
USD965440S1 (en) 2020-06-29 2022-10-04 The Procter And Gamble Company Package
MX2023001042A (es) 2020-07-31 2023-02-16 Procter & Gamble Bolsa fibrosa soluble en agua que contiene granulos para el cuidado del cabello.
JP2023537339A (ja) 2020-08-11 2023-08-31 ザ プロクター アンド ギャンブル カンパニー ブラシシルバリンエシレートを含有する保湿性ヘアコンディショナー組成物
CN116456957A (zh) 2020-08-11 2023-07-18 宝洁公司 含有芸苔油醇缬氨酸酯乙磺酸盐的低粘度毛发调理剂组合物
MX2023001043A (es) 2020-08-11 2023-02-16 Procter & Gamble Composiciones acondicionadoras de enjuague limpio para el cabello que contienen esilato de valinato de brassicilo.
EP4255384A1 (en) 2020-12-01 2023-10-11 The Procter & Gamble Company Aqueous hair conditioner compositions containing solubilized anti-dandruff actives
CN113041230B (zh) * 2021-03-23 2022-06-24 浙江尖峰健康科技有限公司 一种软胶囊的囊皮及由其制备的软胶囊
KR102653460B1 (ko) * 2021-09-01 2024-03-29 한남대학교 산학협력단 콜라겐과 레시틴을 포함하는 분해도 조절이 가능한 스타치 나노섬유의 제조방법
WO2023145886A1 (ja) * 2022-01-31 2023-08-03 三菱ケミカル株式会社 ナノファイバー
CN114808184A (zh) * 2022-03-11 2022-07-29 深圳市法鑫忠信新材料有限公司 一种长效驱蚊的静电纺丝纤维及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527592A (en) * 1974-08-05 1978-10-04 Ici Ltd Wound dressing
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5567439A (en) 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
CA2396640A1 (en) 2001-08-02
KR100806412B1 (ko) 2008-02-21
HUP0301130A3 (en) 2006-07-28
WO2001054667A1 (en) 2001-08-02
TWI289061B (en) 2007-11-01
CN1223340C (zh) 2005-10-19
HUP0301130A2 (hu) 2003-09-29
IL150642A0 (en) 2003-02-12
JP2003521493A (ja) 2003-07-15
NO20023338D0 (no) 2002-07-11
KR20020082212A (ko) 2002-10-30
AU3113401A (en) 2001-08-07
PL356924A1 (en) 2004-07-12
CN1396823A (zh) 2003-02-12
NO20023338L (no) 2002-09-03
NZ519992A (en) 2004-04-30
AU772830B2 (en) 2004-05-06
BR0107869A (pt) 2002-11-05
EP1251829A1 (en) 2002-10-30
EP1251829A4 (en) 2009-05-06
MY129356A (en) 2007-03-30
AR028204A1 (es) 2003-04-30
ZA200205989B (en) 2003-02-03

Similar Documents

Publication Publication Date Title
AU772830B2 (en) Electrospun pharmaceutical compositions
US20030017208A1 (en) Electrospun pharmaceutical compositions
AU2003258120B2 (en) Electrospun amorphous pharmaceutical compositions
US20060083784A1 (en) Amorphous pharmaceutical compositions
AU2004202461B2 (en) Electrospun pharmaceutical compositions
US7856989B2 (en) Electrostatically produced fast dissolving fibers
Mehta et al. Electrospun nanofiber scaffolds: technology and applications
AU2017201378A1 (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
TW200800305A (en) Encapsulation of lipid-based formulations in enteric polymers
Vass et al. Continuous drying of a protein-type drug using scaled-up fiber formation with HP-β-CD matrix resulting in a directly compressible powder for tableting
Pisani et al. Tableted hydrophilic electrospun nanofibers to promote meloxicam dissolution rate
CN114748428A (zh) 一种高载药量的盐酸卡利拉嗪长效缓释微球及其制备方法
CN111450078A (zh) 一种静电纺丝包载纳米颗粒的药物制剂及其制备和应用
CN114681406B (zh) 一种卡利拉嗪长效缓释微球及其制备方法
Thakkar et al. Electrospray particles as drug delivery systems: concepts, strategies, and applications
EP3494970A2 (en) Hardly soluble therapeutic agents belonging to bcs class ii or iv suspended in the liquid formulation and/or in the final nanofibrous structure
Sharma et al. ELECTROSPUN POLYMERIC NANOFIBER FOR SUBLINGUAL DRUG DELIVERY-A REVIEW
Barichello et al. Agatonovic-Kustrin, S., V. Wu, T. Rades, D. Saville, IG Tucker, Powder diffractometric assay of two polymorphic forms of ranitidine hydrochloride 184, 107 Antos-Bielska, M., see Grzybowski, J. 184, 173 Antos-Bielska, M., see Grzybowski, J. 184, 179
CN106309373A (zh) 一种普罗布考固体分散体及其制备

Legal Events

Date Code Title Description
FG Grant or registration